The Bert M. Glaser, MD Award honors innovative early-career research that has significantly advanced retinal disease understanding or treatment, funded by the Association for Research in Vision and Ophthalmology.
Funder: Association for Research in Vision and Ophthalmology
Due Dates: October 1, 2026 (Full application deadline)
Funding Amounts: $10,000 (one-time award; funds must be used to further the recipient's research)
Summary: Recognizes early-career investigators whose innovative research has significantly advanced the understanding or treatment of retinal diseases.
Key Information: Discovery must be within five years of application; ARVO membership required.
This award honors early-career basic scientists or clinician-scientists whose novel research—such as the discovery of a new drug, technique, or fundamental disease mechanism—has had a transformative impact on the understanding or treatment of retinal diseases. Established in memory of Dr. Bert M. Glaser, the award emphasizes innovation that leads to significant advances in clinical practice or scientific knowledge in retina research.